Selby_Lancet_CGH_January.pdf (213.79 kB)
The Lancet Gastroenterology & Hepatology Journal Cover January 2nd 2017
The strongest risk factor for oesophageal adenocarcinoma (OAC) is reflux disease, and the rising incidence coincides with the eradication of Helicobacter pylori, both of which may alter the oesophageal microbiota. We aimed to profile the microbiota at different stages of Barrett’s carcinogenesis and investigate the Cytosponge™ as a minimally invasive tool for sampling the oesophageal microbiota.
Funding
Dr Robert Brierley, Dr Heather Van Epps
History
School
- The Arts, English and Drama
Department
- Arts
Citation
SELBY, A., 2017. The Lancet Gastroenterology & Hepatology Journal Cover January 2nd 2017. The Lancet Gastroenterology & Hepatology Journal, 2(1)Publisher
ElsevierVersion
- VoR (Version of Record)